{
  "title": "Doctors Warn FDA of Risks Posed by Flawed Oxygen Devices",
  "link": "https://www.nytimes.com/2022/11/02/health/pulse-oximeters-black-patients.html",
  "guid": "https://www.nytimes.com/2022/11/02/health/pulse-oximeters-black-patients.html",
  "atom:link": "",
  "description": "Especially for Black patients, inaccurate readings have imperiled care and may have contributed to deaths during the pandemic, experts told an advisory panel.",
  "dc:creator": "Christina Jewett",
  "pubDate": "Wed, 02 Nov 2022 16:33:09 +0000",
  "category": [
    "Coronavirus (2019-nCoV)",
    "Deaths (Fatalities)",
    "Black People",
    "Doctors",
    "Research",
    "Oxygen",
    "Pulse Oximetry",
    "Skin",
    "Medical Devices",
    "Regulation and Deregulation of Industry",
    "Food and Drug Administration"
  ],
  "media:content": "",
  "media:credit": "Grace Cary/Getty Images",
  "media:description": "Officials said that pulse oximeters used in hospitals were marketed based on studies of as few as 10 healthy people. And the devices that people buy online or at retail pharmacies are not scrutinized by the F.D.A."
}